Featured Article
Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before interest and taxes rose 22 % to $674 million over the same period last year. A review of Boston Scientific’s 24 April earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Pricing was not mentioned in their earnings call. Margins were briefly mentioned by…
Read MoreIn This Issue
A business school professor enters the classroom on the first day and asks the class: “What is NBC in the business of…
Read More The best practices in marketing hi-tech new-ventures more closely resemble that of a targeted portfolio management than that of a general portfolio…
Read More In the second article of this series, we explored a model to show the value of trade shows. While our model demonstrated…
Read More Trade Shows are costly marketing efforts. They take sales people out of the field and restrict them to an 8X10 piece of…
Read More